13 not yet recruiting, 12 recruiting, 9 completed, 5 unknown. 20 Not applicable, 2 Phase 2, 2 Phase 3, 1 Phase 4.
Follow Coronary Heart Disease (CHD): new trials by email Literature Review of Coronary Heart Disease (CHD) trials Research Report on Coronary Heart Disease (CHD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effectiveness of Pollution Monitoring in Clinical Exercise Rehabilitation Progressive Walking Exercise Programme, Real-time air quality information and guidance - Cardiovascular Disease, Asthma | Not applicable | Not yet recruiting | University of Leicester | 80 | 2026-10-01 | 2026-10-05 |
| Yiqi Fumai Lyophilized Injection for Chronic Heart Failure Caused by Coronary Heart Disease Yiqi Fumai Lyophilized Injection(YQFM), Stable Guideline-Directed Medical Therapy - Chronic Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF) | Not applicable | Not yet recruiting | China Academy of Chinese Medical Sciences | 100 | 2026-09-01 | 2026-09-09 |
| Real-World Effectiveness and Costs of Yiqi Fumai Lyophilized Injection in Coronary Heart Disease-Related Chronic Heart Failure Yiqi Fumai Lyophilized Injection - Chronic Heart Failure, Coronary Heart Disease (CHD) | Not yet recruiting | China Academy of Chinese Medical Sciences | 200 | 2026-09-01 | 2026-09-25 | |
| Construction and Validation of a Coronary Artery Disease-Specific Large Language Model and Its Evaluation Framework (CorAI) No Intervention: Observational Cohort - Coronary Heart Disease (CHD), Artifical Intelligence | Not yet recruiting | China National Center for Cardiovascular Diseases | 640 | 2026-08-17 | 2026-08-14 | |
| Wearable Assessment of Thoracic, Cardiac Health and Exercise Performance Trial Prospective Apple Watch Series 9 - Congenital Heart Disease, Pulmonary Hypertension | Not yet recruiting | The University of Hong Kong | 20 | 2026-08-01 | 2026-06-23 | |
| Single vs. Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Intervention With DCB-only Strategy (KONG-FREEDOM-I) Drug-coated balloon, Single antiplatelet therapy (SAPT), Dual antiplatelet therapy (DAPT) - Coronary Heart Disease (CHD) | Not applicable | Recruiting | Gan Lijun | 2170 | 2026-05-04 | 2026-08-17 |
| The Effectiveness of a Theory-driven Behavioral Change Intervention on Sedentary Behavior in Individuals With Coronary Heart Disease: A Randomised Controlled Trial A theory-driven behavioural change intervention, Attentive control group - Coronary Heart Disease (CHD) | Not applicable | Not yet recruiting | Chinese University of Hong Kong | 232 | 2026-04-13 | 2026-04-23 |
| The Prognostic Value of Cardiopulmonary Exercise Testing Parameters in Patients With Coronary Heart Disease: A Retrospective Cohort Study(CPETPCAD) Coronary Heart Disease (CHD) | Not yet recruiting | Xinjiang Medical University | 15000 | 2026-04-07 | 2026-04-16 | |
| Proteomic and Inflammatory Omics Changes With Colchicine Therapy in Coronary Heart Disease colchicine - Coronary Heart Disease (CHD) | Phase 4 | Not yet recruiting | Chinese Academy of Medical Sciences, Fuwai Hospital | 176 | 2026-03-01 | 2026-03-19 |
| Scalable Clinical Oversight of Large Language Models Via Uncertainty Triangulation SCOUT-Assisted Review Workflow, Standard Manual Review Workflow - Coronary Heart Disease (CHD) | Not applicable | Not yet recruiting | China National Center for Cardiovascular Diseases | 7 | 2026-02-19 | 2026-02-17 |
| Protective Effect of EECP Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular Surgery Enhanced External Counterpulsation (EECP), Sham Comparator - Coronary Heart Disease (CHD), Cardio-pulmonary Bypass | Not applicable | Not yet recruiting | Nanjing Medical University | 400 | 2025-12-31 | 2024-12-11 |
| Closed-Loop Neurofeedback Targeting the Left Dorsolateral Prefrontal Cortex for Cardiac Autonomic Modulation in Coronary Artery Disease With Anxiety Real-time fNIRS-based neurofeedback - Coronary Heart Disease (CHD), Anxiety Disorders | Not applicable | Recruiting | Shenyang Medical College | 56 | 2025-11-23 | 2026-04-22 |
| Closed-Loop Neurofeedback Targeting the Right Dorsolateral Prefrontal Cortex for Cardiac Autonomic Modulation in Coronary Artery Disease With Anxiety Real-time fNIRS-ECG neurofeedback - Coronary Heart Disease (CHD), Anxiety Disorders | Not applicable | Recruiting | Shenyang Medical College | 56 | 2025-11-19 | 2026-04-22 |
| Coronary Heart Disease Complicated With Ischemic Mitral Regurgitation in China Ischemic Mitral Regurgitation, Coronary Heart Disease (CHD) | Not yet recruiting | China National Center for Cardiovascular Diseases | 6000 | 2025-11-10 | 2025-11-17 | |
| Effectiveness of a Tele-cardiac Rehabilitation (Tele-CR) Program A tele-CR program, Attention-controlled - Coronary Heart Disease (CHD), Coronary Arterial Disease (CAD) | Not applicable | Enrolling by invitation | Chang Gung University of Science and Technology | 126 | 2025-10-01 | 2026-03-20 |
| AI-Driven Dynamic Prediction of Non-Target Lesion Progression After PCI: A Chinese Multicenter Cohort Study percutaneous coronary intervention - Coronary Heart Disease (CHD) | Recruiting | China-Japan Friendship Hospital | 12000 | 2025-09-01 | 2025-12-31 | |
| The Role of 4 Different Consent Approaches on a Pilot Study to Increase Cardiac Rehabilitation Attendance Usual Care Group, More Support and Tools - Ethics, Cardiac Rehabilitation | Not applicable | Active not recruiting | Baystate Medical Center | 160 | 2025-07-16 | 2026-09-30 |
| Verona Coronary Physiology Interventional Registry Coronary physiology assessment using Fractional Flow Reserve (FFR) as per standard of care and angiography-derived FFR - Coronary Artery Disease, Ischemic Heart Disease (IHD) | Active not recruiting | Azienda Ospedaliera Universitaria Integrata Verona | 1000 | 2025-07-14 | 2025-09-22 | |
| Reliability of Multiple-Repetition-Maximum Tests in Patients With Cardiovascular Disease or Risk Factors Heart Failure, Coronary Heart Disease (CHD) | Recruiting | Technical University of Munich | 50 | 2025-07-14 | 2026-10-22 | |
| REsiduAL rISk Under Intensive Lipid-lowering Therapy In Coronary Heart Disease Assessment of residual cholesterol and inflammatory risk factors - Coronary Heart Disease (CHD) | Recruiting | Shanghai Zhongshan Hospital | 900 | 2025-07-01 | 2026-02-03 |
Showing 20 of 44. Sign in to see all of them.
Coronary Disease (44) · Heart Failure (9) · Cardiovascular Diseases (4) · Anxiety Disorders (2) · Asthma (2) · Atherosclerosis (2) · Atrial Fibrillation (2) · Diabetes Mellitus (2) · Heart Defects, Congenital (2) · Hypertension (2) · Myocardial Ischemia (2) · Peripheral Arterial Disease (2) · Pulmonary Disease, Chronic Obstructive (2) · Angina, Stable (1) · Angina, Unstable (1)
Heart Diseases (44) · Vascular Diseases (44) · Myocardial Ischemia (42) · Cardiovascular Diseases (40) · Pathologic Processes (8) · Pathological Conditions, Signs and Symptoms (8) · Arterial Occlusive Diseases (4) · Arteriosclerosis (4) · Endocrine System Diseases (4) · Metabolic Diseases (4) · Nutritional and Metabolic Diseases (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Glucose Metabolism Disorders (3) · Infarction (3) · Ischemia (3)
Amlodipine (1) · Aspirin (1) · Atenolol (1) · Colchicine (1) · Coronary Artery Bypass (1) · Counseling (1) · Enalapril (1) · Enalaprilat (1) · Nitroglycerin (1) · Passive Cutaneous Anaphylaxis (1) · Percutaneous Coronary Intervention (1) · Simvastatin (1) · Trimetazidine (1) · anacetrapib (1) · evolocumab (1)
China National Center for Cardiovascular Diseases (4) · Shanghai Zhongshan Hospital (3) · Beijing Anzhen Hospital (2) · China Academy of Chinese Medical Sciences (2) · Shenyang Medical College (2) · 900th Hospital of PLA Joint Logistic Support Force (1) · Amgen (1) · AstraZeneca (1) · Azienda Ospedaliera Universitaria Integrata Verona (1) · Baystate Medical Center (1) · Chang Gung University of Science and Technology (1) · China-Japan Friendship Hospital (1) · Chinese Academy of Medical Sciences, Fuwai Hospital (1) · Chinese University of Hong Kong (1) · City Hospital No 40, Saint Petersburg, Russia (1)
China (19) · United Kingdom (4) · United States (4) · Australia (3) · Italy (3) · Canada (2) · Czechia (2) · France (2) · Germany (2) · Hong Kong (2) · Hungary (2) · Netherlands (2) · Poland (2) · Spain (2) · Taiwan (2)
Lin Tao, MM (2) · Yun-En Liu, MD (2) · Andre Ng, Ph.D, MD (1) · Ayman El-Menyar (1) · Dmitriy G Lisovetz, MD, CMedSc (1) · Elaine Yi Ning Miu, MSc (1) · Erli Zhang, MD, PhD (1) · Fang Wang (1) · Flavio Ribichini, MD (1) · Harry Hemingway, FRCP (1) · Ho Yu Cheng, PhD (1) · Iftikhar Kullo (1) · Jassim Al Suwaidi (1) · Joao Lima, Professor (1) · Jun-jie Du, MD (1)
PMID 11482918, PMID 15824203, PMID 16253582, PMID 17982182, PMID 1906692, PMID 19781408, PMID 20843569, PMID 21082868, PMID 21670242, PMID 22386286, PMID 24737712, PMID 25670362, PMID 27069105, PMID 27278477, PMID 27379610, PMID 27444506, PMID 28183511, PMID 28331015, PMID 29897428, PMID 29992264, PMID 30170854, PMID 30368735, PMID 30571511, PMID 31487545, PMID 31565793, PMID 31722151, PMID 31797532, PMID 32740442, PMID 33091360, PMID 33156965, PMID 36682076, PMID 36713022, PMID 36847902, PMID 36858690, PMID 38768982, PMID 38956941, PMID 39105679, PMID 39124787, PMID 39660933, PMID 40051028, PMID 40164448, PMID 40582348, PMID 41211925, PMID 41903215, PMID 42153665, PMID 42183757, PMID 42379943, PMID 42663360, PMID 42670293
2018 (1), 2023 (1)